pI: 10.2306 |
Length (AA): 227 |
MW (Da): 25299 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
19 | 141 | 1zav (A) | 3 | 127 | 15.00 | 0 | 0.89 | 0.63 | -0.89 |
5 | 227 | 4nwb (A) | 5 | 245 | 33.00 | 0 | 1 | 1.35958 | -0.42 |
19 | 129 | 1zav (A) | 3 | 115 | 17.00 | 0 | 1 | 0.673087 | -0.79 |
21 | 225 | 3jsy (A) | 11 | 215 | 17.00 | 0 | 1 | 1.20528 | -0.39 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127990)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G25260 | ribosomal protein L10 family protein |
Babesia bovis | BBOV_I004380 | conserved hypothetical protein |
Brugia malayi | Bm1_12395 | ribosomal protein L10 domain containing protein |
Candida albicans | CaO19.12996 | similar to S. cerevisiae MRT4 (YKL009W) involved in rRNA processing and mRNA turnover |
Candida albicans | CaO19.5550 | similar to S. cerevisiae MRT4 (YKL009W) involved in rRNA processing and mRNA turnover |
Caenorhabditis elegans | CELE_F10E7.5 | Protein F10E7.5 |
Cryptosporidium hominis | Chro.70189 | hypothetical protein |
Cryptosporidium parvum | cgd7_1600 | ribosomal protein of the PO/L10 family |
Dictyostelium discoideum | DDB_G0276411 | mRNA turnover protein 4 |
Drosophila melanogaster | Dmel_CG1381 | Ribosomal protein LP0-like |
Echinococcus granulosus | EgrG_000438800 | mrna turnover protein 4 |
Entamoeba histolytica | EHI_159790 | 60S acidic ribosomal protein PO, putative |
Entamoeba histolytica | EHI_102940 | 60S acidic ribosomal protein PO, putative |
Echinococcus multilocularis | EmuJ_000438800 | mrna turnover protein 4 |
Giardia lamblia | GL50803_13412 | Acidic ribosomal protein P0 |
Homo sapiens | ENSG00000053372 | mRNA turnover 4 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.35.4900 | 60S acidic ribosomal protein, putative |
Leishmania donovani | LdBPK_364880.1 | 60S acidic ribosomal protein, putative |
Leishmania infantum | LinJ.36.4880 | 60S acidic ribosomal protein, putative |
Leishmania major | LmjF.36.4650 | 60S acidic ribosomal protein, putative |
Leishmania mexicana | LmxM.36.4650 | 60S acidic ribosomal protein, putative |
Loa Loa (eye worm) | LOAG_02906 | ribosomal protein L10 domain-containing protein |
Mus musculus | 668455 | predicted gene 9178 |
Mus musculus | 434693 | predicted gene 5633 |
Mus musculus | ENSMUSG00000028741 | MRT4, mRNA turnover 4, homolog (S. cerevisiae) |
Neospora caninum | NCLIV_028630 | hypothetical protein, conserved |
Oryza sativa | 9270809 | Os12g0105325 |
Oryza sativa | 4349548 | Os11g0105400 |
Onchocerca volvulus | OVOC3440 | mRNA turnover protein 4 homolog |
Plasmodium berghei | PBANKA_1143500 | ribosome biogenesis protein MRT4, putative |
Plasmodium falciparum | PF3D7_1367600 | ribosome biogenesis protein MRT4, putative |
Plasmodium knowlesi | PKNH_1103600 | ribosome biogenesis protein MRT4, putative |
Plasmodium vivax | PVX_115340 | ribosome biogenesis protein MRT4, putative |
Plasmodium yoelii | PY03082 | Ribosomal protein L10, putative |
Saccharomyces cerevisiae | YKL009W | Mrt4p |
Schistosoma japonicum | Sjp_0004660 | expressed protein |
Schistosoma japonicum | Sjp_0200820 | mRNA turnover protein 4 homolog, putative |
Schistosoma mansoni | Smp_134420 | mRNA turnover protein 4 mrt4 |
Schmidtea mediterranea | mk4.005841.00 | |
Trypanosoma brucei gambiense | Tbg972.10.12210 | 60S acidic ribosomal protein, putative |
Trypanosoma brucei | Tb927.10.10010 | mRNA turnover protein 4 homolog, putative |
Trypanosoma congolense | TcIL3000_10_8350 | 60S acidic ribosomal protein, putative |
Trypanosoma cruzi | TcCLB.508307.170 | 60S acidic ribosomal protein, putative |
Toxoplasma gondii | TGME49_255320 | mRNA turnover 4 (MRT4) family protein |
Theileria parva | TP01_1023 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_447370 | mRNA turnover protein 4 mrt4, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.10010 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.10010 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.10010 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.10010 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F10E7.5 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_255320 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Lmaj006032; Recombinant protein: full-length; Source: L major; 60S acidic ribosomal protein putative ; |